| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anaptysbio, Inc. (ANAB) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. ANAB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 506.9K | $26.17M | - | |
| Other | 42.1K | $2.17M | - | |
| Dir | 39.7K | $2.05M | - | |
| CFO | 25.8K | $1.33M | - | |
| CFO | 21.9K | $1.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | Lizzul Paul F.68 | Chief Medical Officer | Sale+OE | 2,220 | $38.93 | $86,424.60 | -12.6% | -57.0% | -49.9% | |
| Sep 16, 2024 | Mulroy Dennis59 | Chief Financial Officer | Sale+OE | 12,220 | $39.91 | $487,724.60 | -56.3% | -57.0% | -49.9% | |
| Aug 14, 2024 | Lizzul Paul F.68 | Chief Medical Officer | Sale+OE | 2,000 | $40.00 | $80,000.00 | -14.7% | -38.0% | -42.4% | |
| Aug 14, 2024 | Ecor1 Capital, LLC75 | 10% Owner | Buy | 273,972 | $36.50 | $9,999,978.00 | +3.6% | -38.0% | -42.4% | |
| Jul 18, 2024 | Lizzul Paul F.68 | Chief Medical Officer | Sale+OE | 1,500 | $35.00 | $52,500.00 | -11.4% | +0.7% | -24.8% | |
| Jul 15, 2024 | Renton Hollings | Director | Sale+OE | 10,000 | $30.64 | $306,422.48 | -59.5% | +6.2% | -18.6% | |
| Jun 21, 2024 | Fenton Dennis M | - | Sell | 1,950 | $23.17 | $45,181.50 | -50.0% | +56.4% | -3.5% | |
| Jun 18, 2024 | Renton Hollings | Director | Sale+OE | 1,950 | $23.16 | $45,162.00 | -50.0% | +69.2% | +2.2% | |
| May 22, 2024 | Mulroy Dennis59 | Chief Financial Officer | Sell | 1,500 | $23.72 | $35,580.00 | -60.9% | +44.0% | -17.2% | |
| Mar 25, 2024 | Faga Daniel61 | CEO | Sell | 148,940 | $22.76 | $3,389,452.02 | -9.0% | +14.0% | -12.6% |